Association of AT1R expression with transplant glomerulopathy and interstitial fibrosis in kidney transplant recipients
Clinical Scorecard: Correlation Between AT1R Expression Levels and Transplant Glomerulopathy Alongside Interstitial Fibrosis in Kidney Transplant Patients
At a Glance
| Category | Detail |
|---|
| Condition | Chronic allograft dysfunction |
| Key Mechanisms | AT1R signaling and anti-AT1R antibodies contribute to fibrotic processes in kidney transplants. |
| Target Population | Kidney transplant recipients within 60 months post-transplantation. |
| Care Setting | Longitudinal study evaluating kidney transplant biopsies. |
Key Highlights
- AT1R expression in tubular epithelium was found in 44.2% of patients.
- Transplant glomerulopathy and interstitial fibrosis were more frequent in AT1R-positive patients.
- The presence of multiple risk factors, including AT1R expression, was linked to worse long-term graft survival.
Guideline-Based Recommendations
Diagnosis
- Assess AT1R expression and anti-AT1R antibody levels in kidney transplant biopsies.
Management
- Monitor for interstitial fibrosis and transplant glomerulopathy in kidney transplant recipients.
Monitoring & Follow-up
- Evaluate long-term graft outcomes in relation to AT1R-related markers and histopathological findings.
Risks
- Multiple risk factors including AT1R expression and histopathological lesions are associated with long-term allograft loss.
Patient & Prescribing Data
77 kidney transplant recipients analyzed.
AT1R expression and anti-AT1R antibodies may indicate risk for chronic allograft injury.
Clinical Best Practices
- Incorporate assessment of AT1R expression in routine biopsy evaluations.
- Consider the combination of AT1R-related markers with histopathological abnormalities for risk stratification.
Related Resources & Content
